Laparoscopic Versus Vaginal Approach Closure Complications

Laparoscopic Versus Vaginal Approach Closure Complications of Vaginal Vault in Laparoscopic Hysterectomy

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05960292

Enrollment

Registered

2023-07-25

Start date

2023-08-01

Completion date

2024-04-30

Last updated

2023-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vaginal Vault Prolapse

Keywords

Laparoscopic hysterectomy, Vaginal hysterectomy

Brief summary

Hysterectomy is considered as a common operation in Gynecology. Hysterectomy could be made by vaginally, laparoscopically or abdominally. The American Congress of Obstetricians and Gynecologist advises the use of a minimally invasive technique for the sake of women and to decrease hospital stay and costs.

Detailed description

Laparoscopic hysterectomy (LH) is a minimally invasive operation that could be made when vaginal hysterectomy is not accessible due to anatomical problems. Vaginal cuff dehiscence (VCD) is a severe adverse event and occurs more frequently after total laparoscopic hysterectomy (TLH) compared with abdominal and vaginal hysterectomy. The study shows effects of the laparoscopic approach versus the vaginal route for the management of vaginal cuff closure during total laparoscopic hysterectomy on female sexual function.

Interventions

PROCEDURELaparoscopic and Vaginal Hysterectomy

To make a comparison between the Vaginal Vault complications after Hysterectomy

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

FEMALE

Age

40 Years to 80 Years

Healthy volunteers

Inclusion criteria

1. Patients who undergo laparoscopic hysterectomy 2. Age ranged from 40 to 80 years. 3. Patients suffering from chronic pelvic inflammatory disease (PID) 4. Dysfunctional uterine bleeding 5. Adenomyosis 6. Endometriosis 7. Fibroid 8. Endometrial hyperplasia 9. Benign ovarian cyst

Exclusion criteria

* Patients with known malignancy

Design outcomes

Primary

Measure	Time frame	Description
Post operative bleeding (defined as blood loss ≥500 cc)	First 24 hours after The Operations	Amount of lost blood will be measured in terms of assessment of Hemoglobin and Hematocrit levels before and after operation.
Postoperative pain	First 24 hours after The Operations	Assessment of the pain post-operatively in patients with pain score as : Total scores vary from 0 to 10 in this method, with a higher score indicating more severe pain

Countries

Egypt

Contacts

Primary ContactMohamed Adel, MSC

elhoseeeeeeny@gmail.com+201065702255

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026